German-Swiss X-border "pilot success":
This article was originally published in Clinica
Executive Summary
The joint project between Switzerland and Germany that provides healthcare for the local respective populations either side of the border has been described as a"total success" by the German health ministry. Under the pilot project, which began on January 1 2007, 27 health insurers (22 from Switzerland) and 22 hospitals (14 from Germany) have been providing care and reimbursement for border region patients. The project to provide a "decisively" better quality of healthcare for this population was long overdue, said German state secretary for health Marion Caspers-Merk. The model can presumably be replicated in other border regions.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.